About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETED

Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.

NCT04283773•Assiut University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Ovarian NeoplasmsGerm Cell TumorsImmunohistochemistry

Interventions

p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)

Ki67 antibody (DAKO) for malignant cases only

Locations

1

Egypt

Locations (1)

Assiut University

Asyut, Egypt

Key Dates

Start Date

December 24, 2019

Primary Completion Date

April 1, 2021

Completion Date

April 1, 2021

Last Updated

September 8, 2021

Related Studies

RECRUITINGPhase 3

A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

NCT07213804

Ovarian NeoplasmsFallopian Tube Neoplasms+2 more

RECRUITINGPhase 1/2

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Solid Tumor, AdultColorectal Cancer+18 more

RECRUITINGPhase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT06885697

MesotheliomaNeoplasms+6 more

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

NCT07035587

Lung NeoplasmsPancreatic Neoplasms+6 more

Establishment of a Tumor Bank for Tissue Samples

NCT01789229

Ovarian NeoplasmsBreast Neoplasms+4 more

Institut Paoli Calmettes Ovarian Cancer Database

NCT02869568

Ovarian Neoplasms

View all related studies

Sponsors

Lead Sponsor

Assiut University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions